Journal of Public Health Medicine 25:88-90 (2003)
© 2003 Faculty of Public Health Medicine of the Royal Colleges of Physicians of the United Kingdom
For Debate |
From the outside looking in
Mark Charny
Translucency Ltd., 21 St. Georges Square, Worcester WR1 1HX. mark{at}translucency.co.uk
Public health practitioners are often suspicious of colleagues who work with the pharmaceutical industry. But, by analogy with the legal system, public good flows from allowing commercial interests to present their case as strongly as possible within rules set by the government or National Health Service. In court, both parties work within an agreed framework, but each party presents only one side of the argument. Arguing the commercial case balances the drive for innovation against the inertia of the NHS.